Discover 1,758 paid clinical trials in Ann Arbor, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,758
The Pediatric Anesthesia Quality Improvement Project
for
Surgery, Anesthesia, Children
Location: Ann Arbor MI, Cleveland OH, Akron OH, Dayton OH,
Sponsor: The Society for Pediatric Anesthesia
Sex: All
Age: 0 - 21
Code: NCT00674388
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
for
Low Grade Astrocytoma, Low Grade Glioma,
Location: Ann Arbor MI, Detroit MI, Grand Rapids MI, Cleveland OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 2 - 21
Code: NCT04166409
Phase 3, Recruiting
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
for
Heart Failure, Left Ventricular Systolic Dysfunction
Location: Ann Arbor MI, Cleveland OH, Cincinnati OH,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT05714085
Phase 2, Phase 3, Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Ann Arbor MI, Royal Oak MI, Detroit MI, Toledo OH,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT03959085
Phase 3, Recruiting
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
for
Embryonal Rhabdomyosarcoma,
Location: Ann Arbor MI, Royal Oak MI, Detroit MI, Toledo OH,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT05304585
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
for
Low-grade Glioma, Advanced Solid Tumor
Location: Ann Arbor MI, Chicago IL, Washington DC, Saint Louis MO,
Sponsor: Day One Biopharmaceuticals, Inc.
Sex: All
Age: 0 - 25
Code: NCT04775485
Phase 2, Recruiting
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Location: Ann Arbor MI, Royal Oak MI, Detroit MI, Toledo OH,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 30
Code: NCT04322318
Phase 2, Recruiting
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
for
Childhood Medulloblastoma
Location: Ann Arbor MI, Royal Oak MI, Detroit MI, Toledo OH,
Sponsor: Children's Oncology Group
Sex: All
Age: 4 - 21
Code: NCT05382338
Phase 3, Recruiting
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Location: Ann Arbor MI, Ypsilanti MI, Canton MI, Chelsea MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 5 - 60
Code: NCT05675410
Phase 3, Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
for
Ganglioneuroblastoma, Nodular, Neuroblastoma
Location: Ann Arbor MI, Royal Oak MI, Toledo OH, Kalamazoo MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 30
Code: NCT06172296
Phase 3, Recruiting
Project: Every Child for Younger Patients With Cancer
for
Adrenal Gland Pheochromocytoma, Carcinoma In Situ,
Location: Ann Arbor MI, Royal Oak MI, Detroit MI, Toledo OH,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 25
Code: NCT02402244
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
for
Acute Myeloid Leukemia
Location: Ann Arbor MI, Royal Oak MI, Toledo OH, Kalamazoo MI,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT04293562
Phase 3, Recruiting
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
for
Acute Leukemia of Ambiguous Lineage,
Location: Ann Arbor MI, Toledo OH, Kalamazoo MI, Grand Rapids MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 1
Code: NCT06317662
Phase 2, Recruiting
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years Old
for
Congenital Adrenal Hyperplasia
Location: Ann Arbor MI, Chicago IL, Indianapolis IN,
Sponsor: Neurocrine Switzerland GmbH
Sex: All
Age: 0 - 3
Code: NCT07536269
Phase 2, Recruiting
Value For Veterans (V4V)
for
Delivery of Health Care
Location: Ann Arbor MI
Sponsor: VA Ann Arbor Healthcare System
Sex: All
Age: 18+
Code: NCT05026684
Recruiting
Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc
for
Prostate Cancer
Location: Ann Arbor MI, Hines IL, Indianapolis IN,
Sponsor: VA Office of Research and Development
Sex: Male
Age: 18+
Code: NCT06084338
Phase 2, Recruiting
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)